SBIR/STTR Research Award

Nanoparticle scavengers for medical countermeasures against mycotoxin

Award identifier 8c49ed19cf0557e2ae4dda2870895470abb3f2df5877ecd3005467ea21acebf1Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$234,880

Program and phase

STTR · Phase I

Award year

2013

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
LUNA INNOVATIONS INCORPORATED
Proposal award date
Not reported
Contract end date
Not reported
UEI
SJHFCDGKJJC5
Solicitation number
PA12-089
Topic code
NIGMS

Research abstract

DESCRIPTION (provided by applicant): Mycotoxin is naturally occurring and is a toxic small molecule produced by fungi. These fungal toxins are representative of a large number of lipophilic agents that pose significant acute and chronic dangers to militarycombatants as potential warfare agents. There are many examples of mycotoxins, some more acutely potent than others. Mycotoxin is classified as hepatotoxins, nephrotoxins, neurotoxins, immunotoxins, and carcinogens. Mycotoxin could also be a threat to thepublic health due to food, water or air contamination. Currently, there are no treatments for mycotoxin exposure in either the acute or chronic setting, and the lack of an effective therapeutic could be catastrophic. In order to protec the safety and health of military personnel and civilians, there is a need to develop a therapeutic and prophylactic drug, which can effectively reduce concentrations below its toxic level and minimize the incidence of clinical toxicity. Luna proposes to develop nanoparticle scavengers that can efficiently sequester the lipophilic mycotoxins in vivo and facilitate their clearance. Ths nanotechnology-based approach offers the potential to treat people under suspicion of actual or potential mycotoxin poisoning. Phase I effortswill focus on demonstrating proof-of-concept in vivo efficacy at attenuating mycotoxin-induced acute toxicities, and demonstrating the safe use of Luna's nanoparticles in one rodent species. Phase II efforts will focus on IND-enabling preclinical studies.Success of the program will provide a valuable medical countermeasure tool against mycotoxins, and it may also find clinical applications for other lipophilic toxins or for overdosed drug toxicities. The nanoparticle antidotes could be important for the Strategic National Stockpile in preparing for an emergency involving bioterrorism. Thus, this proposed technology is of great interest to the public health, and also enhances the nation's preparedness against potential mycotoxin attacks. PUBLIC HEALTH RELEVANCE PUBLIC HEALTH RELEVANCE: Mycotoxin is naturally occurring and is a toxic small molecule produced by organisms of the fungus kingdom, and it is representative of a large number of lipophilic molecular agents that pose significant acute and chronic dangers to military combatants as potential biochemical warfare agents. There are no current treatments for exposure to such agents, and in a potential event of mycotoxin attack, the lack of an effective therapeutic could be catastrophic. This project proposes the development scavenging nanoparticle based medical countermeasures that are capable of efficiently sequestering lipophilic mycotoxins, and facilitating their excretion in vivo resulting in reduced toxicities.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

994 SBIR/STTR records share this UEI (1991–2026). Reported award amounts total $336,438,763. Reported amounts are not federal obligations.

Phases: Phase I, Phase II, Phase II – Direct to Phase II

Agencies: Department of Defense, National Aeronautics and Space Administration, Department of Energy, Department of Health and Human Services, National Science Foundation, Environmental Protection Agency

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.